SCHEMBL9370584

SCHEMBL9370584

O=C1CN(c2ccccc2)C(=O)C1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ GFER P55789 1/20 0.44
▸ MAPT P10636 4/20 0.41
▸ GAA P10253 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ LMNA P02545 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.38
▸ CTSG P08311 2/20 0.37
▸ DDB1 Q16531 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28279680 0.79 MEN1 (0.41) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL1670432 0.78 KMT2A (0.38) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL1670430 0.78 KMT2A (0.38) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL10580265 0.76 MEN1 (0.45) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL5138888 0.74 LMNA (0.42) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL18328089 0.73 KMT2A (0.42) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL1027868 0.70 KMT2A (0.40) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL17070928 0.70 GRM2 (0.49) KMT2ANPC1RAB9AMEN1GAA
SCHEMBL3498051 0.70 ALDH1A1 (0.50) KMT2ARAB9AMEN1ALDH1A1GFER
SCHEMBL225262 0.69 KMT2A (0.47) KMT2ANPC1RAB9AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103804108-B A kind of method preparing primary amine 沈阳药科大学 2016-08-03 — — CN disclosed
EP-0409163-B1 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors MERRELL DOW PHARMA (US) 1994-12-21 — — EP disclosed
US-5109010-A Lipoxygenase inhibitor; antiasthmic, antiarthritic agent MERRELL DOW PHARMACEUTICALS INC. (US) 1992-04-28 — — US disclosed
US-5026861-A Antiarthritic asthma agent, lipoxygenase inhibitors MERRELL DOW PHARMACEUTICALS (US) 1991-06-25 — — US disclosed
EP-0409163-A2 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-23 — — EP disclosed
Send feedback